Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment

Inflammatory Bowel Diseases

Volumn 13, Issue 4, 2007, Pages 439-445

  Freysdottir, Jona ^a,b   Zhang, Sha ^a   Tilakaratne, Wanninayake M ^c,d   Fortune, Farida ^c  

^a LEEDS DENTAL INSTITUTE   (United Kingdom)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

Crohn's disease; Orofacial granulomatosis; Th1 cells; Th1 associated cytokines

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MACROPHAGE; ORAL BIOPSY; OROFACIAL GRANULOMATOSIS; PRIORITY JOURNAL; TH1 CELL;

CASE-CONTROL STUDIES; CHEMOKINES; CROHN DISEASE; CYTOKINES; GRANULOMATOSIS, OROFACIAL; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, CHEMOKINE; TH1 CELLS;

EID: 34247600456     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20023     Document Type: Article

References (29)

1. Wiesenfeld D, Ferguson MM, Mitchell DN, et al. Oro-facial granulomatosis - a clinical and pathological analysis. Q J Med. 1985;54:101-113.
2. Challacombe SJ. Oro-facial granulomatosis and oral Crohns disease: are they specific diseases and do they predict systemic Crohns disease? Oral Dis. 1997;3:127;
3. Aliment Pharmacol Ther. 129.
4. Leao JC, Hodgson Y, Scully C, et al. Review article: orofacial granulomatosis. Aliment Pharmacol Ther. 2004;20:1019, 1027.
5. Barnard KM, Walker-Smith JA. The prevalence of oral manifestations of inflammatory bowel disease in a paediatric population. J Dent Res. 1994;73:835.
6. Pittock S, Drumm B, Fleming P, et al. The oral cavity in Crohn's disease. J Ped. 2001;138:767-771.
7. Talbot T, Jewell L, Schloss E, et al. Cheilitis antedating Crohn's disease: case report and literature update of oral lesions. J Clin Gastroenterol. 1984;6:349-354.
8. Williams AJK, Wray D, Ferguson A. The clinical entity of orofacial Crohn's disease. Q J Med. 1991;79:451-458.
9. Bogenrieder T, Rogler G, Vogt T, et al. Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent. Dermatology. 2003;206:273-278.
10. van de Scheur MR, van der Waal RIF, Volker-Dieben HJ, et al. Orofacial granulomatosis in a patient with Crohn's disease. J Am Acad Dermatol. 2003;49:952-954.
11. MacDonald TT, Monteleone G, Pender SLF. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol. 2000;51:2-9.
12. Matsumoto T, Nakamura S, Jon-no Y, et al. Role of granuloma in the immunopathogenesis of Crohn's disease. Digestion. 2001;63:43-47.
13. Pallone F, Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut. 1998;43:735-736.
14. Stallmach A, Marth T, Duchmann R, et al. Increased expression of IL-12 receptor transcripts in Crohn's disease (CD) compared to ulcerative colitis (UC) and induction of β2 by stimulation with B7-1. Immunol Lett. 1999;69:A149.
15. Kimiec Z. Cytokines in inflammatory bowel disease. Arch Immunol Ther Exp. 1998;46:143-155.
16. Kudo T, Nagata S, Aoyagi Y, et al. Polarised production of T-helper cell type 1 cells in Peyer's patches in Crohn's disease. Digestion. 2004;70:214-225.
17. Gordon JN, Di Sabatino A, MacDonald TT. The pathologic rationale for biological therapies in inflammatory bowel disease. Curr Opin Gastroenterol 2005;21:431-437.
18. Lim SH, Stephens P, Cao QX, et al. Molecular analysis of T cell receptor β variability in a patient with orofacial granulomatosis. Gut. 1997;40:683-686.
19. Facchetti F, Signorini S, Majorana A, et al. Non-specific influx of T-cell receptor alpha/beta and gamma/delta lymphocytes in mucosal biopsies from a patient with orofacial granulomatosis. J Oral Pathol Med. 2000;29:519-522.
20. Fais S, Capobianchi MR, Pallone F, et al. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. Gut. 1991;32:403-407.
21. Breese E, Braegger CP, Corrigan CJ, et al. Interleukin-2 and interferon-γ secreting T cells in normal and diseased human intestinal mucosa. Immunology. 1993;78:127-131.
22. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology. 1997;112:1169-1178.
23. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-533.
24. + T cell chemokine receptor transcript expression during in vivo type-1 (mycobacterial) and type-2 (schistosomal) immune responses. J Leukoc Biol. 2002;72:363-372.
25. + granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response? Lab Invest. 2005;85:137-145.
26. Huang XR, Kitching AR, Tipping PG, et al. Interleukin-10 inhibits macrophage-induced glomerular injury. J Am Soc Nephrol. 2000;11:262-269.
27. Lebre MC, Burwell T, Vieira PL, et al. Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: A role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation. Immunol Cell Biol. 2005;83:525-535.
28. Berrebi D, Banerjee A, Paris R, et al. In situ RANTES and interferon-γ gene expression in pediatric small bowel Crohn's disease. J Pediatr Gastroenterol Nutr. 1997;25:371-376.
29. Sanderson J, Nunes C, Escudier M, et al. Oro-facial granulomatosis: Crohn's disease or a new inflammatory bowel disease? Inflamm Bowel Dis. 2005;11:840-846.